← Leaderboards
Rama Natarajan
University Of Virginia Charlottesville
$30,287,552
Attributed
$31,900,139
Total exposure
12
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$31,900,139 · 12
By mechanism
R01$28,680,291 · 6
DP3$2,210,571 · 1
R21$459,680 · 1
T32$386,591 · 1
P01$117,586 · 1
M01$45,420 · 2
Top collaborators
- Zhen Bouman Chen4 shared
- Debbie C Thurmond3 shared
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesDiabetes MellitusDiabeticIn VivoMediatingFunctional DisorderLeadInnovationGene ExpressionChromatinHealthcareEpigenetic ProcessRegulationInflammatoryGene Expression RegulationComplications Of Diabetes MellitusTranscription FactorMouse ModelMolecularBlood VesselsGlucoseFundingIn VitroPromotor (Genetics)
Grant awards (81)
Chromatin remodeling factors and mechanisms in diabetic microvascular complications$726,922
R01 · FY2025 · DK · contact PI
DIABETES PREVENTION / RISK / OMICS / METABOLISM / THERAPY (PROMT) INTERDISCIPLINARY TRAINING$152,204
T32 · FY2025 · DK
Transcriptional Regulation by Angiotensin II in Vascular Smooth Muscle Cells$689,810
R01 · FY2024 · HL · contact PI
DIABETES PREVENTION / RISK / OMICS / METABOLISM / THERAPY (PROMT) INTERDISCIPLINARY TRAINING$158,768
T32 · FY2024 · DK
Transcriptional Regulation by Angiotensin II in Vascular Smooth Muscle Cells$703,887
R01 · FY2023 · HL · contact PI
Transforming growth factor beta1, microRNAs, lncRNA and diabetic nephropathy$505,842
R01 · FY2023 · DK · contact PI
DIABETES PREVENTION / RISK / OMICS / METABOLISM / THERAPY (PROMT) INTERDISCIPLINARY TRAINING$75,619
T32 · FY2023 · DK
Transcriptional Regulation by Angiotensin II in Vascular Smooth Muscle Cells$703,887
R01 · FY2022 · HL · contact PI
Transforming growth factor beta1, microRNAs, lncRNA and diabetic nephropathy$505,842
R01 · FY2022 · DK · contact PI
Transcriptional Regulation by Angiotensin II in Vascular Smooth Muscle Cells$703,887
R01 · FY2021 · HL · contact PI
Transforming growth factor beta1, microRNAs, lncRNA and diabetic nephropathy$505,842
R01 · FY2021 · DK · contact PI
Inflammatory Gene Regulation in Diabetic Conditions$450,821
R01 · FY2021 · DK · contact PI
Transforming growth factor beta1, microRNAs, lncRNA and diabetic nephropathy$505,842
R01 · FY2020 · DK · contact PI
Inflammatory Gene Regulation in Diabetic Conditions$450,821
R01 · FY2020 · DK · contact PI
Transcriptional Regulation by Angiotensin II in Vascular Smooth Muscle Cells$432,500
R01 · FY2020 · HL · contact PI
Inflammatory Gene Regulation in Diabetic Conditions$450,821
R01 · FY2019 · DK · contact PI
Transcriptional Regulation by Angiotensin II in Vascular Smooth Muscle Cells$432,500
R01 · FY2019 · HL · contact PI
Inflammatory Gene Regulation in Diabetic Conditions$450,821
R01 · FY2018 · DK · contact PI
Transcriptional Regulation by Angiotensin II in Vascular Smooth Muscle Cells$432,500
R01 · FY2018 · HL · contact PI
Transforming growth factor beta1, microRNAs and diabetic nephropathy$404,212
R01 · FY2018 · DK · contact PI
Transcriptional Regulation by Angiotensin II in Vascular Smooth Muscle Cells$432,500
R01 · FY2017 · HL · contact PI
Transforming growth factor beta1, microRNAs and diabetic nephropathy$412,967
R01 · FY2017 · DK · contact PI
Inflammatory Gene Regulation in Diabetic Conditions$393,414
R01 · FY2017 · DK · contact PI
Transforming growth factor beta1, microRNAs and diabetic nephropathy$419,392
R01 · FY2016 · DK · contact PI
Inflammatory Gene Regulation in Diabetic Conditions$397,538
R01 · FY2016 · DK · contact PI
Role of 12-Lipoxygenase and Growth Factors in Diabetic Nephropathy$365,400
R01 · FY2016 · DK · contact PI
Epigenetic Markers of Complications and Metabolic Memory in the DCCT/EDIC cohort.$2,210,571
DP3 · FY2015 · DK · contact PI
Transforming growth factor beta1, microRNAs and diabetic nephropathy$425,692
R01 · FY2015 · DK · contact PI
Transcriptional Regulation by Angiotensin II in Vascular Smooth Muscle Cells$408,775
R01 · FY2015 · HL · contact PI
Inflammatory Gene Regulation in Diabetic Conditions$406,992
R01 · FY2015 · DK · contact PI
Role of 12-Lipoxygenase and Growth Factors in Diabetic Nephropathy$365,400
R01 · FY2015 · DK · contact PI
Transforming growth factor beta1, microRNAs and diabetic nephropathy$430,598
R01 · FY2014 · DK · contact PI
Inflammatory Gene Regulation in Diabetic Conditions$410,903
R01 · FY2014 · DK · contact PI
Transcriptional Regulation by Angiotensin II in Vascular Smooth Muscle Cells$406,700
R01 · FY2014 · HL · contact PI
Role of 12-Lipoxygenase and Growth Factors in Diabetic Nephropathy$365,400
R01 · FY2014 · DK · contact PI
Transforming growth factor beta1, MicroRNAs and Diabetic Nephropathy$432,267
R01 · FY2013 · DK · contact PI
Inflammatory Gene Regulation in Diabetic Conditions$420,000
R01 · FY2013 · DK · contact PI
Transcriptional Regulation by Angiotensin II in Vascular Smooth Muscle Cells$395,080
R01 · FY2013 · HL · contact PI
Role of 12-Lipoxygenase and Growth Factors in Diabetic Nephropathy$352,612
R01 · FY2013 · DK · contact PI
Transcriptional Regulation by Angiotensin II in Vascular Smooth Muscle Cells$415,000
R01 · FY2012 · HL · contact PI
Nuclear Mechanisms of VSMC Gene Regulation and Cellular Interactions in Diabetes$410,850
R01 · FY2012 · HL · contact PI
Inflammatory Gene Regulation in Diabetic Conditions$391,845
R01 · FY2012 · DK · contact PI
Role of 12-Lipoxygenase and Growth Factors in Diabetic Nephropathy$365,400
R01 · FY2012 · DK · contact PI
Transforming growth factor beta1, MicroRNAs and Diabetic Nephropathy$353,866
R01 · FY2012 · DK · contact PI
Transforming growth factor beta1, MicroRNAs and Diabetic Nephropathy$94,080
R01 · FY2012 · DK · contact PI
Transcriptional Regulation by Angiotensin II in Vascular Smooth Muscle Cells$415,000
R01 · FY2011 · HL · contact PI
Nuclear Mechanisms of VSMC Gene Regulation and Cellular Interactions in Diabetes$415,000
R01 · FY2011 · HL · contact PI
Inflammatory Gene Regulation in Diabetic Conditions$392,710
R01 · FY2011 · DK · contact PI
Transforming growth factor beta1, MicroRNAs and Diabetic Nephropathy$353,866
R01 · FY2011 · DK · contact PI
Nuclear Mechanisms of VSMC Gene Regulation and Cellular Interactions in Diabetes$415,000
R01 · FY2010 · HL · contact PI
Inflammatory Gene Regulation in Diabetic Conditions$399,373
R01 · FY2010 · DK · contact PI
Transforming growth factor beta1, MicroRNAs and Diabetic Nephropathy$394,416
R01 · FY2010 · DK · contact PI
Inflammatory Gene Regulation in Diabetic Conditions$100,000
R01 · FY2010 · DK · contact PI
Nuclear Mechanisms of VSMC Gene Regulation and Cellular Interactions in Diabetes$415,000
R01 · FY2009 · HL · contact PI
Transforming growth factor beta1, MicroRNAs and Diabetic Nephropathy$398,400
R01 · FY2009 · DK · contact PI
Inflammatory Gene Regulation in Diabetic Conditions$394,384
R01 · FY2009 · DK · contact PI
Role of 12-Lipoxygenase in Diabetic Nephropathy$349,065
R01 · FY2009 · DK · contact PI
Role of 12-Lipoxygenase in Diabetic Nephropathy$61,973
R01 · FY2009 · DK · contact PI
Role of 12-Lipoxygenase in Diabetic Nephropathy$417,422
R01 · FY2008 · DK · contact PI
Nuclear Mechanisms of VSMC Gene Regulation and Cellular Interactions in Diabetes$416,667
R01 · FY2008 · HL · contact PI
Inflammatory Gene Regulation in Diabetic Conditions$386,398
R01 · FY2008 · DK · contact PI
New Mechanisms in the Pathogenesis of Diabetic Nephropathy$248,430
R21 · FY2008 · DK · contact PI
Inflammatory Gene Transcription In Diabetic Conditions$378,670
R01 · FY2007 · DK · contact PI
Role of 12-Lipoxygenase in Diabetic Nephropathy$331,681
R01 · FY2007 · DK · contact PI
New Mechanisms in the Pathogenesis of Diabetic Nephropathy$211,250
R21 · FY2007 · DK · contact PI
Role of 12-Lipoxygenase in Diabetic Nephropathy$70,327
R01 · FY2007 · DK · contact PI
MOLECULAR MECHANISMS OF HYPERGLYCEMIA AND DIABETES-INDUCED MONOCYTE ACT$3,875
M01 · FY2007 · RR · contact PI
Inflammatory Gene Transcription In Diabetic Conditions$389,979
R01 · FY2006 · DK · contact PI
Role of 12-Lipoxygenase in Diabetic Nephropathy$355,735
R01 · FY2006 · DK · contact PI
MOLECULAR MECHANISMS OF HYPERGLYCEMIA AND DIABETES-INDUCED MONOCYTE ACT$19,596
M01 · FY2006 · RR · contact PI
Inflammatory Gene Transcription In Diabetic Conditions$399,363
R01 · FY2005 · DK
ROLE OF 12-LIPOXYGENASE IN DIABETIC NEPHROPATHY$350,000
R01 · FY2005 · DK
MOLECULAR MECHANISMS OF HYPERGLYCEMIA AND DIABETES-INDUCED MONOCYTE ACT$14,462
M01 · FY2005 · RR
Inflammatory Gene Transcription In Diabetic Conditions$399,363
R01 · FY2004 · DK
ROLE OF 12-LIPOXYGENASE IN DIABETIC NEPHROPATHY$374,809
R01 · FY2004 · DK
Molecular Mechanisms of Hyperglycemia and Diabetes$7,487
M01 · FY2004 · RR
Inflammatory Gene Transcription In Diabetic Conditions$418,559
R01 · FY2003 · DK
ROLE OF 12-LIPOXYGENASE IN DIABETIC NEPHROPATHY$377,416
R01 · FY2003 · DK
ROLE OF 12-LIPOXYGENASE IN DIABETIC NEPHROPATHY$379,889
R01 · FY2002 · DK
ROLE OF 12-LIPOXYGENASE IN DIABETIC NEPHROPATHY$400,398
R01 · FY2001 · DK
HYPERGLYCEMIA, GROWTH FACTOR ACTION AND LIPID SIGNALLING$117,586
P01 · FY2000 · HL